Viventia Bio Overview

  • Founded
  • 1995

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Viventia Bio General Information

Description

Producer of biopharmaceuticals. The company is engaged in the identification, development, production and marketing of biopharmaceuticals specializing in human monoclonal antibody therapies for the treatment of cancer.

Contact Information

Formerly Known As
Novopharm Biotech
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 147 Hamelin Street
  • Winnipeg, Manitoba R3T 3Z1
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viventia Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viventia Bio‘s full profile, request access.

Request a free trial

Viventia Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of biopharmaceuticals. The company is engaged in the identification, development, production and marketing of b
Biotechnology
Winnipeg, Canada
00.00 0000-00-00
000000&0

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
0000000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit ess
0000 000000000
Cambridge, United Kingdom
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viventia Bio Competitors (76)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfenex Formerly VC-backed San Diego, CA 00 000.00 000000&0 000.00
00000 Formerly VC-backed Cambridge, United Kingdom 000 00000 000000&0 00000
00000000 Corporation Austin, TX 00 0000 00000000 0000
00000000 00000000 Corporate Backed or Acquired College Station, TX 000 0000000000
000000 00000000000 Formerly PE-Backed South San Francisco, CA 00 00000 000000&0 00000
You’re viewing 5 of 76 competitors. Get the full list »

Viventia Bio Patents

Viventia Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6847846-B2 Dosing strategies targeting epcam-positive bladder cancer Active 12-Mar-2015 000000000
US-10583198-B2 Dosing strategies for targeting epcam positive bladder cancer Active 12-Mar-2015 000000000 00
US-20180104355-A1 Dosing strategies for targeting epcam positive bladder cancer Granted 12-Mar-2015 00000000000
JP-2018512402-A Dosing strategy targeting epcam positive bladder cancer Granted 12-Mar-2015 00000000000 0
CA-2979400-A1 Dosing strategies for targeting epcam positive bladder cancer Pending 12-Mar-2015 A61K47/6861
To view Viventia Bio’s complete patent history, request access »

Viventia Bio Executive Team (5)

Name Title Board Seat Contact Info
Gregory Adams Ph.D Chief Development Officer
Stephen Hurly Director, President & Chief Executive Officer
You’re viewing 2 of 5 executive team members. Get the full list »

Viventia Bio Board Members (1)

Name Representing Role Since
000000000 000000 00.0 Self Board Member 000 0000
To view Viventia Bio’s complete board members history, request access »

Viventia Bio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viventia Bio‘s full profile, request access.

Request a free trial